Abnormalities of cAMP signaling in affective disorders: Implications for pathophysiology and treatment

Jorge Perez, Daniela Tardito, Silvia Mori, Giorgio Racagni, Enrico Smeraldi, Raffaella Zanardi

Research output: Contribution to journalArticle

Abstract

Objective: During the last decade, much attention has been given to the role of signal transduction pathways in affective disorders. This review describes the possible role of the cAMP signaling in such disorders. Methods: Among the components of cAMP signaling, this review focuses on the cAMP-dependent phosphorylation system. We analyzed the basic components of the cAMP-dependent phosphorylation system and the preclinical evidence supporting their involvement in the biochemical action of antidepressants and mood stabilizers. The clinical data available until now, concerning the possible link between the cAMP-dependent phosphorylation system and the pathophysiology of affective disorders, are also reviewed. Results: The studies herein presented demonstrated that the levels and the activity of cAMP-dependent protein kinase are altered by antidepressants and mood stabilizers. Furthermore, these medications are able to modify the phosphorylation state, as well as the levels of some of the cAMP-dependent protein kinase substrates. More recently, clinical studies have reported abnormalities in the cAMP-dependent phosphorylation system in both peripheral cells and the postmortem brain of patients with affective disorders. Conclusions: Overall, these studies support an involvement of cAMP signaling in affective disorders. The precise knowledge of the findings has the potential to improve the understanding of pharmacotherapy and to provide directions for the development of novel biochemical and genetic research strategies on the pathogenesis of affective disorders.

Original languageEnglish
Pages (from-to)27-36
Number of pages10
JournalBipolar Disorders
Volume2
Issue number1
Publication statusPublished - Mar 2000

Fingerprint

Mood Disorders
Phosphorylation
Cyclic AMP-Dependent Protein Kinases
Antidepressive Agents
Therapeutics
Genetic Research
Molecular Biology
Signal Transduction
Drug Therapy
Brain

Keywords

  • Affective disorders
  • Antidepressants
  • Mood stabilizers
  • Phosphoproteins
  • PKA

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Perez, J., Tardito, D., Mori, S., Racagni, G., Smeraldi, E., & Zanardi, R. (2000). Abnormalities of cAMP signaling in affective disorders: Implications for pathophysiology and treatment. Bipolar Disorders, 2(1), 27-36.

Abnormalities of cAMP signaling in affective disorders : Implications for pathophysiology and treatment. / Perez, Jorge; Tardito, Daniela; Mori, Silvia; Racagni, Giorgio; Smeraldi, Enrico; Zanardi, Raffaella.

In: Bipolar Disorders, Vol. 2, No. 1, 03.2000, p. 27-36.

Research output: Contribution to journalArticle

Perez, J, Tardito, D, Mori, S, Racagni, G, Smeraldi, E & Zanardi, R 2000, 'Abnormalities of cAMP signaling in affective disorders: Implications for pathophysiology and treatment', Bipolar Disorders, vol. 2, no. 1, pp. 27-36.
Perez J, Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R. Abnormalities of cAMP signaling in affective disorders: Implications for pathophysiology and treatment. Bipolar Disorders. 2000 Mar;2(1):27-36.
Perez, Jorge ; Tardito, Daniela ; Mori, Silvia ; Racagni, Giorgio ; Smeraldi, Enrico ; Zanardi, Raffaella. / Abnormalities of cAMP signaling in affective disorders : Implications for pathophysiology and treatment. In: Bipolar Disorders. 2000 ; Vol. 2, No. 1. pp. 27-36.
@article{f70cf7b95bc745b992597a80f7eac06c,
title = "Abnormalities of cAMP signaling in affective disorders: Implications for pathophysiology and treatment",
abstract = "Objective: During the last decade, much attention has been given to the role of signal transduction pathways in affective disorders. This review describes the possible role of the cAMP signaling in such disorders. Methods: Among the components of cAMP signaling, this review focuses on the cAMP-dependent phosphorylation system. We analyzed the basic components of the cAMP-dependent phosphorylation system and the preclinical evidence supporting their involvement in the biochemical action of antidepressants and mood stabilizers. The clinical data available until now, concerning the possible link between the cAMP-dependent phosphorylation system and the pathophysiology of affective disorders, are also reviewed. Results: The studies herein presented demonstrated that the levels and the activity of cAMP-dependent protein kinase are altered by antidepressants and mood stabilizers. Furthermore, these medications are able to modify the phosphorylation state, as well as the levels of some of the cAMP-dependent protein kinase substrates. More recently, clinical studies have reported abnormalities in the cAMP-dependent phosphorylation system in both peripheral cells and the postmortem brain of patients with affective disorders. Conclusions: Overall, these studies support an involvement of cAMP signaling in affective disorders. The precise knowledge of the findings has the potential to improve the understanding of pharmacotherapy and to provide directions for the development of novel biochemical and genetic research strategies on the pathogenesis of affective disorders.",
keywords = "Affective disorders, Antidepressants, Mood stabilizers, Phosphoproteins, PKA",
author = "Jorge Perez and Daniela Tardito and Silvia Mori and Giorgio Racagni and Enrico Smeraldi and Raffaella Zanardi",
year = "2000",
month = "3",
language = "English",
volume = "2",
pages = "27--36",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "1",

}

TY - JOUR

T1 - Abnormalities of cAMP signaling in affective disorders

T2 - Implications for pathophysiology and treatment

AU - Perez, Jorge

AU - Tardito, Daniela

AU - Mori, Silvia

AU - Racagni, Giorgio

AU - Smeraldi, Enrico

AU - Zanardi, Raffaella

PY - 2000/3

Y1 - 2000/3

N2 - Objective: During the last decade, much attention has been given to the role of signal transduction pathways in affective disorders. This review describes the possible role of the cAMP signaling in such disorders. Methods: Among the components of cAMP signaling, this review focuses on the cAMP-dependent phosphorylation system. We analyzed the basic components of the cAMP-dependent phosphorylation system and the preclinical evidence supporting their involvement in the biochemical action of antidepressants and mood stabilizers. The clinical data available until now, concerning the possible link between the cAMP-dependent phosphorylation system and the pathophysiology of affective disorders, are also reviewed. Results: The studies herein presented demonstrated that the levels and the activity of cAMP-dependent protein kinase are altered by antidepressants and mood stabilizers. Furthermore, these medications are able to modify the phosphorylation state, as well as the levels of some of the cAMP-dependent protein kinase substrates. More recently, clinical studies have reported abnormalities in the cAMP-dependent phosphorylation system in both peripheral cells and the postmortem brain of patients with affective disorders. Conclusions: Overall, these studies support an involvement of cAMP signaling in affective disorders. The precise knowledge of the findings has the potential to improve the understanding of pharmacotherapy and to provide directions for the development of novel biochemical and genetic research strategies on the pathogenesis of affective disorders.

AB - Objective: During the last decade, much attention has been given to the role of signal transduction pathways in affective disorders. This review describes the possible role of the cAMP signaling in such disorders. Methods: Among the components of cAMP signaling, this review focuses on the cAMP-dependent phosphorylation system. We analyzed the basic components of the cAMP-dependent phosphorylation system and the preclinical evidence supporting their involvement in the biochemical action of antidepressants and mood stabilizers. The clinical data available until now, concerning the possible link between the cAMP-dependent phosphorylation system and the pathophysiology of affective disorders, are also reviewed. Results: The studies herein presented demonstrated that the levels and the activity of cAMP-dependent protein kinase are altered by antidepressants and mood stabilizers. Furthermore, these medications are able to modify the phosphorylation state, as well as the levels of some of the cAMP-dependent protein kinase substrates. More recently, clinical studies have reported abnormalities in the cAMP-dependent phosphorylation system in both peripheral cells and the postmortem brain of patients with affective disorders. Conclusions: Overall, these studies support an involvement of cAMP signaling in affective disorders. The precise knowledge of the findings has the potential to improve the understanding of pharmacotherapy and to provide directions for the development of novel biochemical and genetic research strategies on the pathogenesis of affective disorders.

KW - Affective disorders

KW - Antidepressants

KW - Mood stabilizers

KW - Phosphoproteins

KW - PKA

UR - http://www.scopus.com/inward/record.url?scp=0034158322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034158322&partnerID=8YFLogxK

M3 - Article

C2 - 11254016

AN - SCOPUS:0034158322

VL - 2

SP - 27

EP - 36

JO - Bipolar Disorders

JF - Bipolar Disorders

SN - 1398-5647

IS - 1

ER -